According to TipRanks.com, Kupinski is a 4-star analyst with an average return of 11.9% and a 45.0% success rate. Kupinski covers the Services sector, focusing on stocks such as Esports Entertainment Group, Beasley Broadcast Group, and Salem Communications.
Currently, the analyst consensus on QuoteMedia is a Moderate Buy with an average price target of $0.35.
The company has a one-year high of $0.23 and a one-year low of $0.15. Currently, QuoteMedia has an average volume of 20.5K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
QuoteMedia, Inc. engages in the provision of financial data, news feeds, market research information, and financial software solutions to online brokerages, clearing firms, banks, financial service companies, media portals, and public corporations. It operates through the following product lines: Interactive Content and Data Applications, Data Feed Services, and Portfolio Management Systems. The Interactive Content and Data Applications product line consist of a suite of software applications that provide publicly traded company and market information to corporate clients via the Internet. The Data Feed Services product line includes raw streaming real-time market data delivered over the Internet or via dedicated telecommunication lines, and supplemental fundamental, historical, and analytical data, keyed to the same symbology. The Portfolio Management Systems product line comprises Quotestream, Quotestream Mobile, Quotestream Professional, and Web Portfolio Management systems. The company was founded by R. Keith Guelpa and Duane A. Nelson in 1999 and is headquartered in Fountain Hills, AZ.
Read More on QMCI:
- JMP Securities Thinks Trevena’s Stock is Going to Recover
- 3 ‘Strong Buy’ Electric Vehicle Stocks With Triple-Digit Upside Potential
- Needham Thinks Taysha Gene Therapies’ Stock is Going to Recover
- Goldman Sachs Sticks to Its Hold Rating for Invesco (IVZ)
- Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), InflaRx (IFRX) and Aerovate Therapeutics (AVTE)